Global Proteolytic Enzymes Market Size, By Country/Region, 2014–2021 (USD Million)

-
Immunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing. The global immunohistochemistry market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases. In 2015, the diagnostics segment accounted for the largest share of the global immunohistochemistry market. The large share of this segment is attributed to growing prevalence of cancer, and wide application of immunohistochemistry in the diagnosis of cancers, infectious diseases, cardiovascular diseases, and other diseases.
North America dominates the global immunohistochemistry market, and this trend is expected to continue during the forecast period. The large share of North America can be attributed to the fact that the majority of big players operating in the immunohistochemistry market are located in this region. In addition, the increasing geriatric population and rising incidence of chronic diseases like cancer, infectious diseases, and cardiovascular disease in this region are expected to boost the market for diagnostics.
Immunohistochemistry Market
Major Players:
The major players in the immunohistochemistry market are F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck Millipore (U.S.), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).

Comments

Post a Comment

If you have any issue, Let me know ?

Popular posts from this blog

Refurbished Medical Equipment Market Top Players, Business Opportunities, Latest Industry Trends And Applications Till 2021

-
Image
According to a new market research report “ Refurbished Medical Equipment Market  (X-Ray, Ultrasound, MRI, CT Scanner, Nuclear Imaging Systems, Heart-Lung Machine, Surgical, CO2 Monitor, Patient Monitor, Pulse Oximeter, AED Defibrillator, Cath Labs, Neonatal, Endoscopy) – Global Forecast to 2021″ published by MarketsandMarkets, the global market is expected to reach USD 11.91 Billion by 2021, at CAGR of 12.7% from 2016 to 2021. This report studies the global Refurbished Medical Equipment Market over the forecast period of 2016 to 2021. The report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Product On the basis of product, the global Refurbished Medical Equipment Market is divided into 11 major segments, namely, operating room equipment & surgical equipment, patient monitors, defibrillators, neurology equipment, medical imaging equipment, cardiovascul...
Read more

COVID-19 Impact on Behavioral Health Software Market: High Demand for Mental Health Services

-
  Increasing adoption of behavior health software, availability of government funding, government initiatives to encourage EHR adoption in behavioral health organizations, favorable behavioral health reforms in the US, and high demand for mental health services amidst provider shortage are the major factors driving the growth of this market. The  behavioral health software market  is expected to reach USD 2,306 billion by 2022 from USD 1,155 billion in 2017, at a CAGR of 14.8%.  Behavioral/Mental Health Software Market by Component (Service, Software), Delivery (Subscription, Ownership), Functionality (Clinical, Administrative, Financial), End User (Clinic, Hospital, Private Practice, Payer). Opportunity: Growing Emphasis On Subscription Model For enhanced data accessibility and real-time analysis, the subscription model of delivery has emerged as a significant solution for integrated or standalone behavioral health software. This helps healthcare organizations to sh...
Read more

Which technology has a higher adoption rate of companion diagnostics?

-
According to the new market research report “ Companion Diagnostics Market   by Product & Service (Assay, Kit, Software & Service), Technology (PCR, NGS, ISH, IHC), Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), End-User (Pharma Companies, CRO), Region — Global Forecast to 2024 ”, published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The global companion diagnostic market is is projected to reach USD 7.3 billion by 2024 from USD 3.5 billion in 2019, at a CAGR of 15.7%. The growth of the market can be attributed to increasing lung cancer cases, growing number of genetic testing, rising need for personalized medicines, and regulatory guidelines that support the companion diagnostics market. However, uncertainty in the reimbursement scenario in different countries is expected to hinder market growth. Don’t...
Read more